{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "exchange": "NCM", "regularMarketChangePercent": 1.3252971, "regularMarketPrice": 4.205, "firstTradeDateMilliseconds": 1415889000000, "priceHint": 4, "earningsTimestamp": 1683662703, "earningsTimestampStart": 1691492340, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.84, "epsForward": -1.35, "epsCurrentYear": -2.34, "priceEpsCurrentYear": -1.7970086, "sharesOutstanding": 8168790, "bookValue": 1.268, "fiftyDayAverage": 2.9565, "fiftyDayAverageChange": 1.2484999, "fiftyDayAverageChangePercent": 0.42228982, "twoHundredDayAverage": 2.120635, "twoHundredDayAverageChange": 2.084365, "twoHundredDayAverageChangePercent": 0.98289657, "marketCap": 34349760, "forwardPE": -3.1148148, "priceToBook": 3.316246, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "shortName": "Soleno Therapeutics, Inc.", "longName": "Soleno Therapeutics, Inc.", "messageBoardId": "finmb_2520553", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": 0.05499983, "regularMarketTime": 1684180798, "regularMarketDayHigh": 4.25, "regularMarketDayRange": "3.9176 - 4.25", "regularMarketDayLow": 3.9176, "regularMarketVolume": 62655, "regularMarketPreviousClose": 4.15, "bid": 0.0, "ask": 0.0, "bidSize": 11, "askSize": 10, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 4.25, "averageDailyVolume3Month": 75431, "averageDailyVolume10Day": 224840, "fiftyTwoWeekLowChange": 3.355, "fiftyTwoWeekLowChangePercent": 3.9470587, "fiftyTwoWeekRange": "0.85 - 4.5", "fiftyTwoWeekHighChange": -0.29500008, "fiftyTwoWeekHighChangePercent": -0.06555557, "fiftyTwoWeekLow": 0.85, "fiftyTwoWeekHigh": 4.5, "dividendDate": 1507248000, "displayName": "Soleno Therapeutics", "symbol": "SLNO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "203 Redwood Shores Parkway", "address2": "Suite 500", "city": "Redwood City", "state": "CA", "zip": "94065", "country": "United States", "phone": "650 213 8444", "fax": "650 213 8383", "website": "https://soleno.life", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.", "fullTimeEmployees": 25, "companyOfficers": [{"maxAge": 1, "name": "Dr. Anish  Bhatnagar M.D.", "age": 52, "title": "Pres, CEO, COO & Director", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 835200, "fmt": "835.2k", "longFmt": "835,200"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. James H. MacKaness", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 539000, "fmt": "539k", "longFmt": "539,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Patricia C. Hirano", "age": 56, "title": "VP of Regulatory Affairs", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": {"raw": 423800, "fmt": "423.8k", "longFmt": "423,800"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Neil M. Cowen M.B.A., Ph.D., MBA", "title": "Sr. VP of Drug Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kristen  Yen M.S.", "age": 53, "title": "VP of Clinical Operations", "yearBorn": 1969, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}